- Home
- APGE vs DEI Comparison
APGE vs DEI Comparison
Compare APGE & DEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- DEI
- Stock Information
- Founded
- APGE 2022
- DEI 1971
- Country
- APGE United States
- DEI United States
- Employees
- APGE N/A
- DEI N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- DEI Real Estate Investment Trusts
- Sector
- APGE Health Care
- DEI Real Estate
- Exchange
- APGE Nasdaq
- DEI Nasdaq
- Market Cap
- APGE 2.6B
- DEI 2.5B
- IPO Year
- APGE 2023
- DEI 2006
- Fundamental
- Price
- APGE $40.82
- DEI $15.56
- Analyst Decision
- APGE Strong Buy
- DEI Hold
- Analyst Count
- APGE 4
- DEI 10
- Target Price
- APGE $97.50
- DEI $17.78
- AVG Volume (30 Days)
- APGE 1.3M
- DEI 1.4M
- Earning Date
- APGE 08-11-2025
- DEI 08-05-2025
- Dividend Yield
- APGE N/A
- DEI 4.89%
- EPS Growth
- APGE N/A
- DEI N/A
- EPS
- APGE N/A
- DEI 0.32
- Revenue
- APGE N/A
- DEI $995,663,000.00
- Revenue This Year
- APGE N/A
- DEI $1.41
- Revenue Next Year
- APGE $743.14
- DEI $2.29
- P/E Ratio
- APGE N/A
- DEI $49.17
- Revenue Growth
- APGE N/A
- DEI 1.93
- 52 Week Low
- APGE $26.20
- DEI $12.39
- 52 Week High
- APGE $63.50
- DEI $20.50
- Technical
- Relative Strength Index (RSI)
- APGE 52.23
- DEI 51.71
- Support Level
- APGE $37.05
- DEI $15.38
- Resistance Level
- APGE $42.29
- DEI $16.14
- Average True Range (ATR)
- APGE 2.01
- DEI 0.39
- MACD
- APGE 0.18
- DEI -0.06
- Stochastic Oscillator
- APGE 77.66
- DEI 32.86
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About DEI Douglas Emmett Inc.
Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. It is an owner and operator of office and multifamily properties located in coastal submarkets in Los Angeles and Honolulu. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments, the office segment and the multifamily segment.